Read More

Eunion Officially Establishes Global Foundation

New York, NY,October11, 2022- (SEAPRWire) – Recently, Eunion is pleased to announce that with the joint efforts and coordination of many parties, the Eunion Global Foundation was officially established. This is an important step for Eunion to go international, and it is also a milestone in Eunion’s global process. The establishment of Eunion Global Foundation enables Eunion to fully guarantee the development of marketization, specialization, and compliance. The Eunion trading team was established in 2013. The company originated in Europe. The team is committed to clearing transactions in the traditional financial (securities, stocks, foreign exchange) field. The team designs and develops trading programs and actually operates to obtain stable income from clearing transactions. Eunion has EU regulatory license MTR (digital currency transaction service license number: FRK000990, digital currency wallet service license number: FVR001101), US regulatory license MSB (license number: 31000164318323), Australian AUSTRAC license (regulatory number: DCE100666271-001) as solid backing. At the same time, it has gained multiple honors around the world, including the “WBC Global Partner Certifi...

Read More

SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development

Singapore, Jun 15, 2022 - (ACN Newswire via SEAPRWire.com) - The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meeting offers a neutrally organized forum to discuss lessons learned and better prepare the healthcare system for the next challenges. From 12-13 July, representatives from Regulatory agencies, health authorities (Ali Al dalaan,[SFDA] Wen-Yi Hung[TFDA] Shin-ichi Okudaira [PMDA]) Jesusa Joyce N. CIRUNAY [Philippines FDA] and industry leaders (Serena Chan [Syneos Health], Daniela Caiazza [Novotech], Ralf Altenburger[Roche], Yu LIANG [MSD], and many more) meet in person for the first time in two years to foster positive changes in the healthcare environment in the Asia-Pacific. That includes emerging technologies, innovations in cancer care, digital health and improved patient access to novel therapies.Sessions discussing Digital Health, Decentralized Clinical Trials, and access to Innovative TherapiesConnecting different perspectives and interests in a neutral forum allows an open dialogue and facilitates solutions and concrete action points for today's healthcare challenges, ...

China’s bid to rival US as debt haven at risk after crackdowns

TORONTO (BLOOMBERG) - To a world full of fixed-income investors starved of safe assets with attractive yields, China's government bonds had become a tempting sight in recent years. However, red flags are now being hoisted. A series of government crackdowns on everything from property developers to technology firms is triggering questions about whether a sudden change in regulations could harm foreign investment in the securities. While positive inflation-adjusted interest rates and relatively tame volatility are keeping some fund managers bullish on China's sovereign debt, the regulatory risk is combining with a lacklustre credit rating to dampen the allure. That's making Chinese bonds a less likely candidate to challenge US Treasuries as global haven assets, impeding Beijing's push to promote the yuan's worldwide usage and dent the dollar's dominance. "I can't help but feel a higher regulatory risk for the nation's bonds," said Akira Takei, a global fixed-income money manager at Asset Management One in Tokyo who has yet to buy the securities. "Although I don't expect any restrictions to be introduced in China's government bond market, I have to examine how tighter regulations outs...